378 related articles for article (PubMed ID: 12471132)
1. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells.
Akhiani AA; Pappo J; Kabok Z; Schön K; Gao W; Franzén LE; Lycke N
J Immunol; 2002 Dec; 169(12):6977-84. PubMed ID: 12471132
[TBL] [Abstract][Full Text] [Related]
2. IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice.
Akhiani AA; Stensson A; Schön K; Lycke NY
J Immunol; 2005 Jun; 174(12):8144-53. PubMed ID: 15944323
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection.
Akhiani AA; Schön K; Franzén LE; Pappo J; Lycke N
J Immunol; 2004 Apr; 172(8):5024-33. PubMed ID: 15067084
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice.
Smythies LE; Waites KB; Lindsey JR; Harris PR; Ghiara P; Smith PD
J Immunol; 2000 Jul; 165(2):1022-9. PubMed ID: 10878379
[TBL] [Abstract][Full Text] [Related]
5. Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient mice.
Akhiani AA; Schön K; Lycke N
J Immunol; 2004 Sep; 173(5):3348-56. PubMed ID: 15322198
[TBL] [Abstract][Full Text] [Related]
6. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
Akhiani AA; Stensson A; Schön K; Lycke N
Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
[TBL] [Abstract][Full Text] [Related]
7. Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice.
Li B; Chen L; Sun H; Yang W; Hu J; He Y; Wei S; Zhao Z; Zhang J; Li H; Zou Q; Wu C
Sci Rep; 2015 Oct; 5():14793. PubMed ID: 26434384
[TBL] [Abstract][Full Text] [Related]
8. Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice.
Goto T; Nishizono A; Fujioka T; Ikewaki J; Mifune K; Nasu M
Infect Immun; 1999 May; 67(5):2531-9. PubMed ID: 10225917
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent.
Garhart CA; Heinzel FP; Czinn SJ; Nedrud JG
Infect Immun; 2003 Feb; 71(2):910-21. PubMed ID: 12540573
[TBL] [Abstract][Full Text] [Related]
10. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model.
Sawai N; Kita M; Kodama T; Tanahashi T; Yamaoka Y; Tagawa Y; Iwakura Y; Imanishi J
Infect Immun; 1999 Jan; 67(1):279-85. PubMed ID: 9864227
[TBL] [Abstract][Full Text] [Related]
11. Intranasal immunization with an epitope-based vaccine results in earlier protection, but not better protective efficacy, against Helicobacter pylori compared to subcutaneous immunization.
Li H; Zhang J; He Y; Li B; Chen L; Huang W; Zou Q; Wu C
Immunol Res; 2015 Jul; 62(3):368-76. PubMed ID: 26044541
[TBL] [Abstract][Full Text] [Related]
12. Defining the Roles of IFN-γ and IL-17A in Inflammation and Protection against Helicobacter pylori Infection.
Sjökvist Ottsjö L; Flach CF; Nilsson S; Malefyt Rde W; Walduck AK; Raghavan S
PLoS One; 2015; 10(7):e0131444. PubMed ID: 26168305
[TBL] [Abstract][Full Text] [Related]
13. Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis.
Sommer F; Wilken H; Faller G; Lohoff M
Infect Immun; 2004 Feb; 72(2):1029-35. PubMed ID: 14742550
[TBL] [Abstract][Full Text] [Related]
14. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice.
Eaton KA; Mefford M; Thevenot T
J Immunol; 2001 Jun; 166(12):7456-61. PubMed ID: 11390498
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis.
Raghavan S; Svennerholm AM; Holmgren J
Infect Immun; 2002 Aug; 70(8):4621-7. PubMed ID: 12117975
[TBL] [Abstract][Full Text] [Related]
16. Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice.
Karachunski PI; Ostlie NS; Monfardini C; Conti-Fine BM
J Immunol; 2000 May; 164(10):5236-44. PubMed ID: 10799884
[TBL] [Abstract][Full Text] [Related]
17. Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection.
Xie Y; Zhou NJ; Gong YF; Zhou XJ; Chen J; Hu SJ; Lu NH; Hou XH
World J Gastroenterol; 2007 Mar; 13(10):1547-53. PubMed ID: 17461447
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 blockade inhibits induction of Helicobacter pylori-associated gastritis in mice.
Watanabe K; Murakami K; Sato R; Okimoto T; Maeda K; Nasu M; Nishizono A; Fujioka T
Clin Exp Immunol; 2004 Jan; 135(1):29-34. PubMed ID: 14678261
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-155 is essential for the T cell-mediated control of Helicobacter pylori infection and for the induction of chronic Gastritis and Colitis.
Oertli M; Engler DB; Kohler E; Koch M; Meyer TF; Müller A
J Immunol; 2011 Oct; 187(7):3578-86. PubMed ID: 21880981
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice.
Taylor JM; Ziman ME; Huff JL; Moroski NM; Vajdy M; Solnick JV
Vaccine; 2006 Jun; 24(23):4987-94. PubMed ID: 16621176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
